S&P 500Dow JonesNASDAQ 100DAX 40MDAXSDAXTecDAXATXSMICAC 40AEXBEL 20IBEX 35
Home/SDAX/STRATEC
STRATEC

STRATEC

SBS.DESDAX
19,52 €
Dividend yield3,07 %
Continuity25 yr
Dividend0,60 €
ISINDE000STRA555
DiviScore
43SCORERisk
Performance1/35
Dividend Quality25/35
AGM Date
23.06.2026
Ex-Date
24.06.2026
Payment
26.06.2026
CAGR 3Y
-27.6%
CAGR 5Y
-31.6%
CAGR 10Y
-9.2%

€10,000 invested in 2016 · with dividend reinvestment

+-56%
End Value
4.389,41 €
Total Return
+-56.1%
Annual Return
-7.9% p.a.
Dividends Received
1.581,32 €

Dividend history

25 years continuous
YearAmountDividend yieldAGM dateEx-datePayment dateChange
20250,60 €23.06.202624.06.202626.06.20260.0%
20240,60 €27.06.202530.06.202502.07.2025+9.1%
20230,55 €17.05.202420.05.202422.05.2024-43.3%
20220,97 €17.05.202318.05.202322.05.2023+2.1%
20210,95 €20.05.202223.05.202225.05.2022+5.6%
20200,90 €20.05.202121.05.202125.05.2021+7.1%
20190,84 €10.05.202009.06.202009.07.2020+2.4%
20180,82 €30.04.201930.05.201929.06.2019+2.5%
20170,80 €01.05.201831.05.201830.06.2018+3.9%
20160,77 €16.05.201715.06.201715.07.2017+2.7%

About STRATEC

Stratec SE is a Germany-based developer and manufacturer of fully automated analyzer systems for partners in clinical diagnostics and biotechnology. Founded in 1979 and headquartered in Birkenfeld, the company specializes in automation solutions for in-vitro diagnostics and life sciences, including sample preparation, integrated laboratory software, and complex consumables for diagnostic and medical applications. As an original equipment manufacturer (OEM), Stratec SE covers the entire value chain—from specification and design to production and quality assurance—enabling partners to market complete system solutions alongside their reagents to laboratories, blood banks, and research institutes worldwide. Notable innovations include the world’s first fully automated luminescence analyzer in 1989 and ongoing advancements through acquisitions like Diatron MI in 2016 for hematology systems and Natech Plastics in 2023 for polymer-based consumables. With subsidiaries across Europe, the US, China, and beyond, and approximately 1,450 employees, Stratec SE leverages patented technologies to serve major diagnostic firms in the healthcare sector, emphasizing precision and reliability in laboratory automation.

IndustryMedical Devices
SectorHealthcare
KGV (PE)14.20
Payout Ratio47.2%
ROE-1.4%

Frequently Asked Questions

The next payment date is 26.06.2026.
STRATEC has a DiviScore of 43/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
STRATEC's current dividend yield is 3.07% based on the latest dividend.
STRATEC (SBS.DE) is a member of SDAX. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.